A smile. A clean validation. A five-step fix. Three ways the same seat stays empty.
Three questions this month.
How does an unowned AI decision pass review?
Why can no one see it?
And what closes it?
Same seat, three angles.
Start with the one that passes review.
MOVEMENT ONE — THE NOD
"Is it governed?"
A nod.
The weakest answer in the room.
And it passes every time.
Black Book asked 182 hospital leaders
what slows their AI governance.
One in three named the same barrier.
Unclear ownership.
Between IT.
Between quality.
Between compliance.
No single name on the decision.
A nod costs nothing to give.
So the committee agrees.
The board signs.
Everyone looks covered.
Three weeks later
the recommendation reaches a patient.
And no one owns the call.
Distributed ownership reads as coverage.
It functions as absence.
Owned by three departments
is owned by none of them
the moment something goes wrong.
MOVEMENT TWO — THE BLIND SPOT
So why does no one see it.
Because a clean validation
reads as a closed question.
Stanford tested the best clinical AI agents
on real medical record tasks.
The strongest were wrong on one in three.
The validation held.
The deployment moved.
No one asked who owns the call.
In the eye, a scotoma is a blind spot.
Not darkness.
Nothing.
The defect is not that you see a gap.
The defect is that nothing looks missing.
The brain fills it in.
The picture looks whole.
Governance has the same defect.
The deployment is approved.
The validation is clean.
The chart reads complete.
Nothing looks missing.
The seat is empty anyway.
The gap is invisible
from the chair the executive sits in.
MOVEMENT THREE — THE KICKSTART AUDIT
So how do you close it.
Not with a policy.
Not with a committee.
Not with a vendor contract.
The deployment.
Only 22 percent of hospital leaders
say they could hand a regulator
a complete auditable AI explanation
in 30 days.
The rest are not ready.
Five steps close the distance.
Map the deployment.
Name the seats.
Interview the Decision Owner.
Build the Handoff map.
Get the sign-off.
Both seats sign.
In writing.
Before the next deployment goes live.
The sign-off is the moment
the seat gets a name.
RESOLUTION — THE ARCHITECTURE
Three angles.
One seat.
The Governance Owner
names what the agent is authorized to do.
The Decision Owner
holds the clinical call.
The Handoff between them
is where the accountability trail builds.
The Accountability Gap™ (TAG™)
does not close with a better model.
It does not close with a cleaner validation.
It does not close with a sharper question.
It closes with a name.
Before the recommendation
reaches the bedside.
You already know
which deployment in your institution
has an empty seat.
You have known for a while.
The only question left
is whether you name it
before something forces you to.
MedicoVigilance™ is published every two weeks by Mo Johnson, MD MBA, founder of GPe Research. Each issue teaches one piece of the clinical AI accountability discipline your institution needs before the next deployment decision.
Forward this to a colleague whose institution has an empty seat behind a system already reaching patients.